(Q58844415)

English

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov

In more languages

Statements

0 references

medical condition

stomach neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

thyroid neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

breast neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

endometrial neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

gallbladder neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

biliary tract neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

pancreatic neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

esophageal neoplasm

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

tumor of testis and paratestis

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

cancer immunotherapy

1 reference

https://clinicaltrials.gov/ct2/show/NCT00423254

Nevada Cancer Institute

0 references

18 year

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58844415&oldid=1590836118"